RISK FACTOR MODIFICATION AFTER MYOCARDIAL-INFARCTION

[1] [Anonymous], 1965, LANCET, V2, P501

[2] [Anonymous], 1982, Lancet, V2, P1173

[3] [Anonymous], 1968, LANCET, V2, P693

[4] [Anonymous], 1984, ARCH INTERN MED, V144, P1045

[5] [Anonymous], 1978, J Chronic Dis, V31, P201

[6] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23): : 3233 - 3240

[7] BROWNER WS, 1988, IN PRESS HYPERTENSIO

[8] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255

[9] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36

[10] MANAGEMENT OF PATIENTS AFTER MYOCARDIAL-INFARCTION [J]. HOSPITAL PRACTICE, 1987, 22 (04): : 149 - &

[1] [Anonymous], 1965, LANCET, V2, P501

[2] [Anonymous], 1982, Lancet, V2, P1173

[3] [Anonymous], 1968, LANCET, V2, P693

[4] [Anonymous], 1984, ARCH INTERN MED, V144, P1045

[5] [Anonymous], 1978, J Chronic Dis, V31, P201

[6] BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23): : 3233 - 3240

[7] BROWNER WS, 1988, IN PRESS HYPERTENSIO

[8] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255

[9] CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36

[10] MANAGEMENT OF PATIENTS AFTER MYOCARDIAL-INFARCTION [J]. HOSPITAL PRACTICE, 1987, 22 (04): : 149 - &